Abstract |
The association of lymphoid neoplasms and antiphospolipid antibodies (APA), with or without thromboembolic complications, has been reported in several cases. We describe one case of B-cell non-Hodgkinís lymphoma (NHL) in which the combination of rituximab with standard chemotherapy led to the complete remission of a severe hypercoagulable state associated with APA.
|
Authors | Dino Veneri, Achille Ambrosetti, Massimo Franchini, Federico Mosna, Giovanni Poli, Giovanni Pizzolo |
Journal | Haematologica
(Haematologica)
Vol. 90 Suppl
Pg. ECR37
(Nov 2005)
ISSN: 1592-8721 [Electronic] Italy |
PMID | 16266928
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Murine-Derived
- Anticoagulants
- Rituximab
- Vincristine
- Warfarin
- Doxorubicin
- Cyclophosphamide
- Heparin
- Prednisone
|
Topics |
- Antibodies, Monoclonal
(therapeutic use)
- Antibodies, Monoclonal, Murine-Derived
- Anticoagulants
(therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, therapeutic use)
- Antiphospholipid Syndrome
(etiology)
- Combined Modality Therapy
- Cyclophosphamide
(administration & dosage)
- Doxorubicin
(administration & dosage)
- Heparin
(therapeutic use)
- Humans
- Immunotherapy
- Lymphoma, B-Cell
(complications, drug therapy, immunology, surgery)
- Male
- Middle Aged
- Prednisone
(administration & dosage)
- Pulmonary Embolism
(drug therapy, etiology)
- Recurrence
- Remission Induction
- Rituximab
- Splenectomy
- Thrombophilia
(drug therapy, etiology)
- Thrombophlebitis
(drug therapy, etiology)
- Vincristine
(administration & dosage)
- Warfarin
(therapeutic use)
|